Skip to content

Clinical trials

Phase 2 Intestinal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intestinal Diseases Phase: Phase 2 Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20081
20092
20105
20141
20163
20173
20182
20192
20211
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status5
Terminated4
Withdrawn1
Recruiting1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
Menarini Group2
Nihon Pharmaceutical Co., Ltd2
Bausch Health Americas, Inc.1
Catalysis SL1
Eli Lilly and Company1
Facet Biotech1
Furiex Pharmaceuticals, Inc1
Hoffmann-La Roche1
ImmusanT, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intestinal Diseases28
Gastrointestinal Diseases15
Digestive System Diseases14
Colonic Diseases9
Colorectal Neoplasms8
Gastrointestinal Neoplasms7
Intestinal Neoplasms7
Digestive System Neoplasms6
Neoplasms6
Neoplasms by Site5

Trials

Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.